Nawroth, F., Tandler-Schneider, A., & Bilger, W. (2015). Multicenter, noninterventional, post-marketing surveillance study to evaluate dosing of recombinant human follicle-stimulating hormone using the redesigned follitropin alfa pen in women undergoing ovulation induction. Drug Healthc Patient Saf.
Citação norma ChicagoNawroth, Frank, Andreas Tandler-Schneider, and Wilma Bilger. "Multicenter, Noninterventional, Post-marketing Surveillance Study to Evaluate Dosing of Recombinant Human Follicle-stimulating Hormone Using the Redesigned Follitropin Alfa Pen in Women Undergoing Ovulation Induction." Drug Healthc Patient Saf 2015.
Citação norma MLANawroth, Frank, Andreas Tandler-Schneider, and Wilma Bilger. "Multicenter, Noninterventional, Post-marketing Surveillance Study to Evaluate Dosing of Recombinant Human Follicle-stimulating Hormone Using the Redesigned Follitropin Alfa Pen in Women Undergoing Ovulation Induction." Drug Healthc Patient Saf 2015.